• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

INVO Bioscience

Invo Bioscience increases offerings in Canada through acquisition

September 9, 2021 By Sean Whooley

Invo Bioscience (OTCQB:IVOB) announced today that it acquired a Canadian-based entity formed to offer its InvoCell platform in Canada. The unnamed entity previously completed a number of important procedures and the documentation required to establish InvoCell within clinical operations in Canada, according to a news release. The acquisition included a $25,000 cash payment and 30,000 […]

Filed Under: Business/Financial News, Gynecological, Mergers & Acquisitions, Women's Health Tagged With: INVO Bioscience

Invo Bioscience names chief financial officer

June 15, 2021 By Danielle Kirsh

Invo Bioscience (OTCQB:IVOB) today announced that it has appointed Andrea Goren as CFO. Goren has more than 27 years of experience in finance. He has held a number of leadership roles at Phoenix Group, Shamrock Group and Madison Capital Group. “Andrea has been serving Invo over the past year in a consulting capacity and thus […]

Filed Under: Business/Financial News Tagged With: INVO Bioscience, Personnel Moves

Invo Bioscience raises $2.1m

May 29, 2020 By Sean Whooley

Invo Bioscience (OTCQB:IVOB) filed an SEC Form D to confirm the sale of more than $2.1 million in equity, debt and other warrants and options. The Sarasota, Fla.-based company made its first sale in the new notice on May 15, collecting the more than $2.1 million from eight investors so far. The offering is not being […]

Filed Under: Business/Financial News, Funding Roundup, Gynecological, Women's Health Tagged With: INVO Bioscience

Invo Bioscience to study extended use of fertility system

February 6, 2020 By Nancy Crotti

Invo Bioscience (OTCQB:IVOB) has received FDA approval to begin a clinical trial of its modified InvoCell system. The trial will measure InvoCell’s effectiveness in achieving fertilization, implantation, embryo development, clinical pregnancy and live birth after 5 days of continuous vaginal incubation, according to the Sarasota, Fla.-based company. The device is currently cleared for 3-day use. The […]

Filed Under: Clinical Trials, Featured, Food & Drug Administration (FDA), Gynecological, Regulatory/Compliance, Women's Health Tagged With: FDA, ferringpharmaceuticals, INVO Bioscience

Invo Bioscience signs Indian distribution deal

January 22, 2020 By Chris Newmarker

Invo Bioscience (OTCQB:IVOB) recently announced that it has inked a joint venture with Medesole Healthcare and Trading Private Limited to market and distribute the InvoCell in vivo fertility system in India. The joint venture will be called Medesole Invo Bioscience India Private Limited and is expected to open and operate dedicated InvoCell clinics only in India, […]

Filed Under: Business/Financial News, Gynecological Tagged With: INVO Bioscience

Invo Bioscience signs European distribution deal

November 13, 2019 By Sean Whooley

Invo Bioscience (OTCQB:IVOB) announced that it entered into commercialization agreements covering Turkey and Jordan to support the company’s expansion into Eurasia. The commercialization agreements are in place to spread the Lakewood Ranch, Fla.–based company’s InvoCell in vivo fertility system to the Eurasia area. Invo Bioscience said research shows that an estimated 15% to 20% of the […]

Filed Under: Business/Financial News, Gynecological Tagged With: INVO Bioscience

Invo Bioscience wins CE Mark for InvoCell fertility device

October 28, 2019 By Sean Whooley

INVO Bioscience (OTCQB:IVOB) said last week that it received CE Mark approval for its InvoCell culture and retention device as an alternative to traditional in vitro fertilization treatment. InvoCell won FDA de novo approval in November 2015 and was launched in the U.S. in April 2016. Currently, it is distributed throughout the U.S. under an $8 […]

Filed Under: Regulatory/Compliance, Women's Health Tagged With: INVO Bioscience

Nelipak names Roger Prevot CEO | Personnel Moves, Oct. 16, 2019

October 16, 2019 By Sean Whooley

Nelipak Corp. said last week that Roger Prevot will take over as CEO, following the retirement of current CEO Michael Kelly. Kelly was in charge when private equity giant Kohlberg bought Nelipak for an undisclosed amount July 2. Kelly is retiring after overseeing the deal and positioning the company for the next phase of its […]

Filed Under: Business/Financial News, Featured Tagged With: Boston Scientific, conformis, electroCore, INVO Bioscience, Johnson and Johnson, Kohlberg Kravis Roberts & Co, Lyra Therapeutics, Miach Orthopaedics, Nelipak, Personnel Moves, Q'Apel Medical, Sientra

INVO Bioscience prices $13m offering

September 10, 2019 By Sean Whooley

INVO Bioscience (OTCQB:IVOB) yesterday registered a common stock offering of more than $13 million, according to a regulatory filing. The Lakewood Ranch, Fla.-based company is putting up nearly 41 million shares of its common stock for close to $13.1 million. There are currently nearly 39 million outstanding shares, according to the filing. They are traded […]

Filed Under: Featured, Funding Roundup, Gynecological, News Well, Wall Street Beat, Women's Health Tagged With: INVO Bioscience

INVO Bioscience touts two women’s ability to carry the same baby

November 5, 2018 By Nancy Crotti

INVO Bioscience today announced that a child had been born to a same-sex couple in which both partners were able to carry the baby in separate phases of the pregnancy. The couple, Bliss and Ashleigh Coulter of Mountain Springs, Texas, welcomed their son, Stetson, in late October. The women and their doctors used INVO Bioscience’s […]

Filed Under: Featured, Implants, Women's Health Tagged With: INVO Bioscience

Invo Bioscience launches InvoCell in US

April 20, 2016 By Fink Densford

INVO Bioscience said today it launched its InvoCell intravaginal culture infertility treatment system in the U.S., starting in Texas through the Center for Assisted Reproduction. INVOcell is designed for incubating eggs and sperm during fertilization during early embryo development and operates within a woman’s body, unlike in vitro fertilization which takes place in a laboratory, the company […]

Filed Under: Business/Financial News, Regenerative Medicine Tagged With: INVO Bioscience

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS